NEOS Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

NEOS Investment Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,799	Closed	-$384K	–	584
2025 Q4	$384K	Sell	1,799 -1,883	-51%	-$389K	﹤0.01%	627
2025 Q3	$732K	Sell	3,682 -396	-10%	-$73.9K	0.01%	551
2025 Q2	$704K	Sell	4,078 -2,028	-33%	-$330K	0.01%	503
2025 Q1	$952K	Sell	6,106 -12,934	-68%	-$1.85M	0.02%	444
2024 Q4	$2.62M	Buy	19,040 +5,736	+43%	+$754K	0.06%	253
2024 Q3	$1.99M	Buy	13,304 +2,467	+23%	+$333K	0.06%	265
2024 Q2	$1.48M	Sell	10,837 -323	-3%	-$43.9K	0.06%	265
2024 Q1	$1.69M	Buy	11,160 +7,378	+195%	+$1.05M	0.1%	190
2023 Q4	$476K	Buy	+3,782	New	+$377K	0.05%	295

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NEOS Investment Management's ASND Position: Q1 2026 in Review

NEOS Investment Management sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 1,799 shares — an estimated $384K sold.

NEOS Investment Management first reported a position in ASND in Q4 2023 and held it in 9 quarters. The position peaked at $2.62M in Q4 2024. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

NEOS Investment Management reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
NEOS Investment Management sold 1,799 Ascendis Pharma A/S shares in Q1 2026, an estimated $384K.
NEOS Investment Management first reported a position in Ascendis Pharma A/S in Q4 2023 and held it in 9 quarters.
NEOS Investment Management's Ascendis Pharma A/S position peaked at $2.62M in Q4 2024.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.